![Brian Adams](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Brian Adams
General Counsel bei RELAY THERAPEUTICS, INC.
Vermögen: 2 Mio $ am 31.05.2024
Aktive Positionen von Brian Adams
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
RELAY THERAPEUTICS, INC. | General Counsel | 01.03.2018 | - |
Unternehmenssekretär | 01.03.2018 | - |
Karriereverlauf von Brian Adams
Ehemalige bekannte Positionen von Brian Adams
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
KERYX BIOPHARMACEUTICALS | General Counsel | 15.04.2014 | 13.03.2018 |
Unternehmenssekretär | 15.04.2014 | 13.03.2018 | |
ALGETA ASA | General Counsel | 01.03.2012 | 01.03.2014 |
Ausbildung von Brian Adams
Harvard University | Undergraduate Degree |
Columbus School of Law | Graduate Degree |
Statistik
International
Vereinigte Staaten | 5 |
Norwegen | 2 |
Operativ
General Counsel | 3 |
Corporate Secretary | 2 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
RELAY THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Keryx Biopharmaceuticals, Inc.
![]() Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Keryx Biopharmaceuticals, Inc. engaged in the manufacture, development, and commercialization of medicines for use in treating human diseases. The company was founded in August 1, 2002 and was headquartered in Cambridge, MA. | Health Technology |
Algeta ASA
![]() Algeta ASA Pharmaceuticals: MajorHealth Technology Algeta ASA is engaged in the development of products for the treatment of cancer. The company focuses on the development of anti-cancer drugs, and its research and development of compounds focuses on the various applications of a few base compounds. Its products, Alpharadin and Thorium-227, are being developed for treatment of skeletal metastases originating from prostate and breast cancer. The company was founded by Roy H. Larsen and Øyvind Sverre Bruland in 1997 and is headquartered in Oslo, Norway. | Health Technology |
- Börse
- Insiders
- Brian Adams
- Erfahrung